Home/Filings/4/0001235802-17-000168
4//SEC Filing

Morrison Gregory 4

Accession 0001235802-17-000168

CIK 0001492658other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:34 PM ET

Size

15.7 KB

Accession

0001235802-17-000168

Insider Transaction Report

Form 4
Period: 2017-11-10
Morrison Gregory
Global VP, Human Resources
Transactions
  • Sale

    Ordinary Shares, par value EUR 0.03 per share

    2017-11-10$23.74/sh50,140$1,190,41977,488 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-11-10$20.62/sh39,241$809,14939,307 total
    Exercise: $20.62Exp: 2025-10-13Ordinary Shares (39,241 underlying)
  • Exercise/Conversion

    Ordinary Shares, par value EUR 0.03 per share

    2017-11-10$21.24/sh+10,899$231,49588,387 total
  • Exercise/Conversion

    Ordinary Shares, par value EUR 0.03 per share

    2017-11-10$20.62/sh+39,241$809,149127,628 total
  • Sale

    Ordinary Shares, par value EUR 0.03 per share

    2017-11-13$23.65/sh42,000$993,10335,488 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-11-10$21.24/sh10,899$231,49523,991 total
    Exercise: $21.24Exp: 2026-07-19Ordinary Shares (10,899 underlying)
Footnotes (5)
  • [F1]Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.62 to $24.02, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.51 to $23.82, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  • [F4]This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
  • [F5]This option vested with respect to 25% of the shares on October 13, 2016 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.

Issuer

Wright Medical Group N.V.

CIK 0001492658

Entity typeother

Related Parties

1
  • filerCIK 0001329922

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:34 PM ET
Size
15.7 KB